Thiopental Sodium E.I.P.I.C.O.

Thiopental sodium is a rapid-acting barbiturate used for anesthesia induction. This sterile injectable form is designed for intravenous use in clinical settings. It provides short-term sedation and hypnosis during medical procedures. Always administered by healthcare professionals only.

Thiopental sodium is primarily used to induce anesthesia before surgery or medical procedures. It is also employed for managing increased intracranial pressure and as part of a rapid sequence intubation protocol. The drug provides quick onset of unconsciousness, making it suitable for emergency situations. It is not intended for routine pain relief or long-term sedation.

After intravenous administration, thiopental sodium produces rapid sedation and unconsciousness within seconds. Effects typically last for 5 to 10 minutes, allowing for brief medical interventions. Some patients may experience temporary drowsiness or confusion upon recovery. Respiratory depression is a common effect during administration.

Thiopental sodium should only be administered by trained medical professionals in a controlled environment. Patients with porphyria or severe cardiovascular disease require careful monitoring. Equipment for resuscitation should be readily available. Dosage must be individualized based on patient response and clinical condition.

Concurrent use with other central nervous system depressants, such as opioids or benzodiazepines, may enhance sedation effects. Alcohol consumption should be avoided before and after administration. Certain medications, including CYP enzyme inhibitors, may alter thiopental sodium metabolism. Always disclose all medications to the administering healthcare provider.